Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, for the ACCESS Study Group, Mark Tidswell et al.|JAMA|2013Cited by 797
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, Daniel P. Rossignol, Derek C. Angus et al.|Unknown|2013Cited by 7